Hepatic inflammation

Hepatic inflammation is not a specific molecule, enzyme, receptor, or protein, but rather a physiological and pathological process characterized by inflammation of the liver tissue, commonly referred to as hepatitis[1][2][3]. It can be caused by a variety of agents, including viruses (hepatitis A, B, C, D, E), excessive alcohol consumption, autoimmune reactions, drugs, toxins, metabolic disorders (e.g., non-alcoholic fatty liver disease), and other insults[1][2][3]. Persistent or chronic hepatic inflammation can lead to liver fibrosis, cirrhosis, and even liver failure or cancer if unchecked[2][3][5]. While "hepatic inflammation" is a valid biological process and a key feature of liver disease, it is not a therapeutic target in the conventional sense (i.e., not a single molecule or protein to which a drug can be directly targeted). Instead, drug development focuses on the underlying causes (e.g., antiviral drugs for viral hepatitis, immunosuppressants for autoimmune hepatitis, lifestyle interventions for steatohepatitis) or the pathways involved in the inflammatory response (e.g., TNF inhibitors, other anti-inflammatory agents)[2][4]. Biomarkers for hepatic inflammation include elevated liver enzymes (ALT, AST), presence of viral antigens/antibodies, and imaging or biopsy findings[2]. In summary, "hepatic inflammation" is a medical condition or pathological state, not a molecular target. For drug discovery, one would focus on the specific molecules, pathways, or etiologies driving the inflammation, not "hepatic inflammation" itself.

Other names

Liver inflammationHepatitis